Record title
Bevacizumab plus chemotherapy versus chemotherapy alone as second-line treatment for patients with HER2-negative locally recurrent or metastatic breast cancer after first-line treatment with bevacizumab plus chemotherapy (TANIA): an open-label, randomised phase 3 trial
Record identifier
TN_cdi_proquest_miscellaneous_1751228383
Record permalink
https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1751228383
Share
Bevacizumab plus chemotherapy versus chemotherapy alone as second-line treatment for patients with HER2-negative locally recurrent or metastatic breast cancer after first-line treatment with bevacizumab plus chemotherapy (TANIA): an open-label, randomised phase 3 trial
About this item
Full title
Author / Creator
Publisher
England: Elsevier Ltd
Journal title
Record Identifier
Language
English
Formats
Publication information
Publisher
Subjects
More information
Scope and Contents
Contents
Alternative Titles
Full title
Authors, Artists and Contributors
Author / Creator
Puglisi, Fabio, MD
Cortes, Javier, MD
Vrdoljak, Eduard, Prof
Marschner, Norbert, MD
Zielinski, Christoph, Prof
Villanueva, Cristian, MD
Romieu, Gilles, MD
Lang, István, Prof
Ciruelos, Eva, MD
De Laurentiis, Michele, MD
Veyret, Corinne, Prof
de Ducla, Sabine, DEA
Freudensprung, Ulrich, MSc
Srock, Stefanie, MD
Gligorov, Joseph, MD
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1751228383
Permalink
https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1751228383
Other Identifiers
ISSN
E-ISSN
DOI